Mandate

Vinge advises Advania’s shareholders in connection with the divestment to funds managed by Goldman Sachs

Vinge has advised the IT-provider company Advania with the divestment of a majority of the shares to funds managed by Goldman Sachs alongside management, VIA Equity and other reinvesting shareholders.

Today headquartered in Stockholm, Advania is a leading full-service IT-provider with a presence in all Nordic countries, delivering mission-critical IT solutions to meet every need.  Advania employs around 1,400 individuals in 27 locations in Sweden, Iceland, Norway, Finland and Denmark. Advania today has a turnover more than SEK 5bn, having delivered more than 20% growth each of the last five years. 

Goldman Sachs is a global leader in private equity, with a strong track record of investing in the technology sector and in the Nordics. To partner with them is not only a stamp of approval of what we have achieved so far but also a promise to everyone here at Advania that the journey ahead will be full of excitement and new possibilities. Most important is that we can stay true to our core ambition: to be a real partner to all customers and a great workplace that keeps on attracting the best talent, says Mikael Noaksson, Advania’s group CEO.

Vinge’s team consisted of Peter Sundgren, Joacim Rydergård, Samra Baytar, Elsie Nassar, Nina Gransäter and Gustav Persson (M&A), Axel Jansson and Rebecka Målquist (Banking and Finance), Jolene Reimerson and Mathilda Persson (Commercial Agreements), Sara Strandberg (Employment), Karl-Hugo Engdahl (IT & GDPR), Sofia Bergenstråhle (Intellectual Property), Karolina Cohrs (Real Property), John Wahlbom (Competition law), Tove Lövgren Frisk (Compliance) and Jessica Öijer and Nathalie Hughes (VDR).

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026